Embolectomy/Thrombectomy Systems, Hydrodynamic, Intravascular

Definition : Systems designed to restore blood flow to arteries and veins occluded with a stationary blood clot (i.e., thrombus) or a mass lodged in the vasculature (i.e., embolus) using hydrodynamic technology. These systems typically consist of a central unit (console) usually mounted on a cart that includes a pump to deliver the liquid (e.g., saline solution) at high speed through a detachable intravascular catheter; controls for the volume and flow of the infused solution; and a monitor to show the performance of the system (e.g., run time, liquid volume and speed) and the type of catheter used. A set of detachable dedicated (e.g., coronary, peripheral) catheters may be used with the console; the catheters usually are double-lumen devices that inject a high-velocity liquid (e.g., saline solution) jet near their distal tip, creating a hydrodynamic vortex. As a consequence of the pressure reduction (Venturi effect), thrombus and/or embolus is sucked, fragmented, and removed, typically into a collection bag. Intravascular embolectomy/thrombectomy hydrodynamic systems are intended to restore normal flow of blood and to permit better visualization of the disease area, reducing the risk of further embolization. These systems are mainly used in procedures performed in catheterization laboratories.

Entry Terms : "Hydrotherapy Systems" , "Cardiac Catheterization Equipment" , "Angioplasty Systems, Hydrodynamic" , "Embolectomy/Thrombectomy Systems" , "Embolectomy/Thrombectomy Systems, Endovascular, Hydrodynamic" , "Hydrodynamic Angioplasty Systems" , "Hydrodynamic Systems" , "Hydrodynamic Therapy System" , "Hydrodynamic Units, Embolectomy/Thrombectomy, Intravascular" , "Intravascular Embolectomy Hydrodynamic Systems" , "Intravascular Thrombectomy Hydrodynamic Systems"

UMDC code : 27009

U.S.companies only
Suppress Subsidiary Companies

1-4 of 4 Match(es).

Ascensia Diabetes Care US Inc

Company Type: Parent

Bayer HealthCare

Company Type: Parent


Company Type: Parent

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005.

Spectranetics Corp

Company Type: Parent

The Spectranetics Corporation was founded in the 1980s on excimer laser technology and today markets the only Excimer Laser System approved in the United States, Canada, Europe and Japan for use in minimally invasive interventional procedures within the cardiovascular system.

1-4 of 4 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone